Marie Annick Buendia
- Hepatology top 1%
- Cancer Research top 2%
- Epidemiology top 2%
- Hepatitis B Virus Studies 12
- Liver Disease Diagnosis and Treatment 4
- Molecular Biology top 5%
- Cancer-related gene regulation 6
- Wnt/β-catenin signaling in development and cancer 5
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology top 5%
- Cancer-related Molecular Pathways 8
-
- Virus-based gene therapy research 5
Marie Annick Buendia
27 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Hepatology 856
- Cancer Research 938
- Epidemiology 1.2k
- Molecular Biology 1.9k
- Oncology 637
Countries citing papers authored by Marie Annick Buendia
This map shows the geographic impact of Marie Annick Buendia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Annick Buendia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Annick Buendia more than expected).
Fields of papers citing papers by Marie Annick Buendia
This network shows the impact of papers produced by Marie Annick Buendia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Annick Buendia. The network helps show where Marie Annick Buendia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marie Annick Buendia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 23 | |
| 2 | 2012 | 37 | |
| 3 | 2012 | 20 | |
| 4 | 2011 | 36 | |
| 5 | 2010 | 335 | |
| 6 | 2006 | 166 | |
| 7 | 2005 | 145 | |
| 8 | 2004 | 18 | |
| 9 | miR-122, a Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1breakdown → | 2004 | 696 |
| 10 | 2004 | 181 | |
| 11 | 2002 | 18 | |
| 12 | 2002 | 26 | |
| 13 | 2002 | 50 | |
| 14 | 2002 | 93 | |
| 15 | 2001 | 17 | |
| 16 | 2000 | 255 | |
| 17 | 1998 | 151 | |
| 18 | 1997 | 244 | |
| 19 | 1992 | 13 | |
| 20 | 1992 | 108 |
About Marie Annick Buendia
Marie Annick Buendia is a scholar working on Hepatology, Oncology and Epidemiology, having authored 27 papers that have together received 3.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (12 papers), Cancer-related Molecular Pathways (8 papers), Cancer-related gene regulation (6 papers), Virus-based gene therapy research (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Hepatology (856 citations), Cancer Research (938 citations) and Epidemiology (1.2k citations). Marie Annick Buendia has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Christine Neuveut, Wei Yu, Claire-Angélique Renard, Pierre Tiollais, Delphine Cougot, Laurence Lévy, Thomas D. Moloshok, William S. Mason, Chunxiao Xu and Jinhong Chang. Their work appears in journals such as Oncogene, Journal of Hepatology, Molecular and Cellular Biology, RNA Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.